ARCHIVES

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009